219 related articles for article (PubMed ID: 31892977)
1. Liposarcoma: Advances in Cellular and Molecular Genetics Alterations and Corresponding Clinical Treatment.
Yang L; Chen S; Luo P; Yan W; Wang C
J Cancer; 2020; 11(1):100-107. PubMed ID: 31892977
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of the Aurora kinase inhibitors AMG 900, AZD1152-HQPA, and MK-5108 on SW-872 and 93T449 human liposarcoma cells.
Noronha S; Alt LAC; Scimeca TE; Zarou O; Obrzut J; Zanotti B; Hayward EA; Pillai A; Mathur S; Rojas J; Salamah R; Chandar N; Fay MJ
In Vitro Cell Dev Biol Anim; 2018 Jan; 54(1):71-84. PubMed ID: 29197031
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Molecular Spectrum of Liposarcoma.
Lee ATJ; Thway K; Huang PH; Jones RL
J Clin Oncol; 2018 Jan; 36(2):151-159. PubMed ID: 29220294
[TBL] [Abstract][Full Text] [Related]
4. Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin.
Beird HC; Wu CC; Ingram DR; Wang WL; Alimohamed A; Gumbs C; Little L; Song X; Feig BW; Roland CL; Zhang J; Benjamin RS; Hwu P; Lazar AJ; Futreal PA; Somaiah N
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29610390
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the management of liposarcoma.
Nassif NA; Tseng W; Borges C; Chen P; Eisenberg B
F1000Res; 2016; 5():2907. PubMed ID: 28105325
[TBL] [Abstract][Full Text] [Related]
6. New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort.
Hoffman A; Lazar AJ; Pollock RE; Lev D
Drug Resist Updat; 2011 Feb; 14(1):52-66. PubMed ID: 21169051
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.
Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; Smid M; van Ijcken WF; Coindre JM; Chibon F; Verhoef C; Mathijssen RH; den Bakker MA; Verweij J; Sleijfer S; Wiemer EA
Int J Cancer; 2014 Jul; 135(2):348-61. PubMed ID: 24375455
[TBL] [Abstract][Full Text] [Related]
8. Different mRNA expression profile during tumor progression in a well-differentiated liposarcoma--A microdissection approach.
Schneider-Stock R; Gerresheim F; Kolin-Gerresheim I; Meyer F; Jäger V; Epplen JT; Roessner A; Boltze C
Pathol Res Pract; 2003; 199(6):445-50. PubMed ID: 12924448
[TBL] [Abstract][Full Text] [Related]
9. Influence of age and subtype in outcome of operable liposarcoma.
Greto D; Saieva C; Loi M; Terziani F; Visani L; Garlatti P; Lo Russo M; Muntoni C; Becherini C; Topulli J; Campanacci D; Beltrami G; Scoccianti G; Muratori F; Bonomo P; Desideri I; Francolini G; Livi L
Radiol Med; 2019 Apr; 124(4):290-300. PubMed ID: 30421387
[TBL] [Abstract][Full Text] [Related]
10. Liposarcoma: A clinicopathological study of 73 cases diagnosed at King Faisal Specialist Hospital and Research Centre.
Nemanqani D; Mourad WA; Akhtar M; Moreau P; Rostom A; Ezzat A; Amin T
Ann Saudi Med; 1999; 19(4):299-303. PubMed ID: 17277528
[TBL] [Abstract][Full Text] [Related]
11. Liposarcoma miRNA signatures identified from genome-wide miRNA expression profiling.
Zhou Y; Zhang Y; Huang Y; Tan R; Liu T; Zhuang R; Zhu M; Han W; Hou Y; Liu J; Zhang L; Jiang Y; Tong H; Shao Y; Zhu J; Lu W
Future Oncol; 2014 Jun; 10(8):1373-86. PubMed ID: 25052748
[TBL] [Abstract][Full Text] [Related]
12. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.
Lyle PL; Bridge JA; Simpson JF; Cates JM; Sanders ME
Histopathology; 2016 Jun; 68(7):1040-5. PubMed ID: 26542423
[TBL] [Abstract][Full Text] [Related]
13. Histology driven systemic therapy of liposarcoma-ready for prime time?
Grethlein SJ
Transl Gastroenterol Hepatol; 2018; 3():96. PubMed ID: 30603732
[TBL] [Abstract][Full Text] [Related]
14. Liposarcomas: diagnostic pitfalls and new insights.
Dei Tos AP
Histopathology; 2014 Jan; 64(1):38-52. PubMed ID: 24118009
[TBL] [Abstract][Full Text] [Related]
15. FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells.
Rodriguez R; Rubio R; Gutierrez-Aranda I; Melen GJ; Elosua C; García-Castro J; Menendez P
Stem Cells; 2011 Feb; 29(2):179-92. PubMed ID: 21732477
[TBL] [Abstract][Full Text] [Related]
16. Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study.
Italiano A; Di Mauro I; Rapp J; Pierron G; Auger N; Alberti L; Chibon F; Escande F; Voegeli AC; Ghnassia JP; Keslair F; Laé M; Ranchère-Vince D; Terrier P; Baffert S; Coindre JM; Pedeutour F
Lancet Oncol; 2016 Apr; 17(4):532-538. PubMed ID: 26970672
[TBL] [Abstract][Full Text] [Related]
17. Whole blood miRNA expression analysis reveals miR-3613-3p as a potential biomarker for dedifferentiated liposarcoma.
Fricke A; Cimniak AFV; Ullrich PV; Becherer C; Bickert C; Pfeifer D; Heinz J; Stark GB; Bannasch H; Braig D; Eisenhardt SU
Cancer Biomark; 2018; 22(2):199-207. PubMed ID: 29689704
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of liposarcoma].
Ubayama Y
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1597-602. PubMed ID: 3296958
[TBL] [Abstract][Full Text] [Related]
19. Vulvar Myxoid Liposarcoma and Well Differentiated Liposarcoma With Molecular Cytogenetic Confirmation: Case Reports With Review of Malignant Lipomatous Tumors of the Vulva.
Schoolmeester JK; Leifer AJ; Wang L; Hameed MR
Int J Gynecol Pathol; 2015 Jul; 34(4):390-5. PubMed ID: 25851712
[TBL] [Abstract][Full Text] [Related]
20. Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia.
Orvieto E; Furlanetto A; Laurino L; Dei Tos AP
Semin Diagn Pathol; 2001 Nov; 18(4):267-73. PubMed ID: 11757867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
